Is MEDOF or XYLD a better dividend investment in 2026?

MEDOF currently yields 4.00% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: XYLD offers higher current income.

What is the dividend yield difference between MEDOF and XYLD?

MEDOF has a forward dividend yield of 4.00% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 6.98 percentage points.

Home › Compare › MEDOF vs XYLD

MEDOF vs XYLD: Dividend Comparison 2026

MEDOF yields 4.00% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MEDOF wins by $668.00 in total portfolio value

INVESTMENT

TIME HORIZON10 years

MEDOF

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$517.11

Full MEDOF calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — MEDOF vs XYLD

📍 MEDOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MEDOF	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MEDOF + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MEDOF pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDOF

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$439.54/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, XYLD beats the other by $2,296.62/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDOF + XYLD for your $10,000?

MEDOF: 50%XYLD: 50%

100% XYLD50/50100% MEDOF

Portfolio after 10yr

$25.6K

Annual income

$1,868.07/yr

Blended yield

7.29%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MEDOF right now

MEDOF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

4.2

Piotroski

5/9

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDOF buys

XYLD buys

No recent congressional trades found for MEDOF or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMEDOFXYLD

Forward yield	4.00%	10.98% ✓
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$25.9K ✓	$25.3K
Annual income after 10y	$517.11	$3,219.02 ✓
Total dividends collected	$4.6K	$19.6K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: MEDOF vs XYLD ($10,000, DRIP)

Year	MEDOF Portfolio	MEDOF Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$11,100	$400.00	$10,818	$1,098.39	+$282.00 → MEDOF
2	$12,292	$414.95	$11,738	$1,222.51	+$554.00 → MEDOF
3	$13,582	$429.45	$12,774	$1,364.64	+$808.00 → MEDOF
4	$14,976	$443.47	$13,944	$1,527.86	+$1.0K → MEDOF
5	$16,481	$457.01	$15,270	$1,715.87	+$1.2K → MEDOF
6	$18,105	$470.04	$16,775	$1,933.09	+$1.3K → MEDOF
7	$19,855	$482.57	$18,490	$2,184.87	+$1.4K → MEDOF
8	$21,739	$494.59	$20,450	$2,477.63	+$1.3K → MEDOF
9	$23,767	$506.10	$22,697	$2,819.19	+$1.1K → MEDOF
10	$25,948	$517.11	$25,280	$3,219.02	+$668.00 → MEDOF

MEDOF vs XYLD: Complete Analysis 2026

MEDOF — Stock

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Full MEDOF Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this MEDOF vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDOF vs SCHD MEDOF vs JEPI MEDOF vs O MEDOF vs KO MEDOF vs MAIN MEDOF vs QYLD MEDOF vs JEPQ MEDOF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.